Table 2 G6PD deficiency prevalence and its associated demographic factors among participants included in the mass blood survey (n = 1973).

From: Factors hindering coverage of targeted mass treatment with primaquine in a malarious township of northern Myanmar in 2019–2020

Sociodemographic factors

G6PDd (n = 266)

G6PDn (n = 1707)

cOR (95% CI)

aOR (95% CI)

p

n (%)

n (%)

Gender

 Female

127 (11.2)

1,004 (88.8)

Ref

Ref

 

 Male

139 (16.5)

703 (83.5)

1.6 (1.21–2.03)

2.1 (1.63–4.09)

 < 0.001*

Ethnicity

 Burmese

6 (5.1)

112 (94.9)

Ref

1

 

 Kadu

60 (10.5)

510 (89.5)

2.2 (0.93–5.21)

2.4 (1.50–7.11)

0.037*

 Kanan

92 (16.4)

469 (83.6)

3.7 (1.56–8.58)

4.1 (2.23–10.2)

0.001*

 Shan

108 (14.9)

616 (85.1)

3.3 (1.40–7.63)

3.6 (2.50–7.98)

0.003*

Living place (village)

 PayKone

14 (6.8)

193 (93.2)

Ref

Ref

 

 ManKat

63 (16.3)

324 (83.7)

2.7 (1.46–4.91)

2.8 (1.88–5.56)

 < 0.001*

 PintSinTe

49 (12.4)

345 (87.6)

2.0 (1.05–3.64)

2.0 (1.55–4.41)

0.017*

 NantHnyin

94 (15.9)

499 (84.1)

2.6 (1.45–4.66)

2.9 (1.65–5.35)

 < 0.001*

 NaungKan

46 (11.7)

346 (88.3)

1.8 (0.98–3.42)

1.7 (0.99–3.31)

0.028*

  1. G6PDd G6PD deficient, G6PDn G6PD normal, cOR crude odds ratio, aOR adjusted odds ratio, CI confidence interval, Ref. reference.
  2. *Significance at p < 0.05.
Back to article page